# Eosera, Inc. – FDA Inspection, Apr 28, 2025

Source: https://www.keypedia.com/records/fda_inspections/eosera-inc/d587b33b-e13d-4322-8bcc-32a754573761
Source feed: FDA_Inspections

> FDA inspection 1269635 of Eosera, Inc., April 28, 2025. 2 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1269635
- Company Name: Eosera, Inc.
- Inspection Date: 2025-04-28
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Dallas District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1308346 - 2026-03-20](https://www.keypedia.com/records/fda_inspections/eosera-inc/6a760a07-14f0-4bff-8ac2-037a6b847e72)
- [FDA Inspection 1165791 - 2022-03-01](https://www.keypedia.com/records/fda_inspections/eosera-inc/809c8c78-0695-434f-9552-a3a9c12e8c0c)
- [FDA Inspection 1115592 - 2020-01-17](https://www.keypedia.com/records/fda_inspections/eosera-inc/3221668e-fad4-4ca7-b173-8cba754bd210)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/kevin-t-nguyen/5ae9d562-7e4f-4305-895a-4b39c35acd16)
- [Investigator](https://www.keypedia.com/people/shelby-n-turner/77268f33-ae48-4e30-abad-4d79c1077185)

Company: https://www.keypedia.com/companies/eosera-inc/703b6159-ec09-448d-a592-b17026014ed1

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9
